[Leser-Trélat sign associated with Sézary syndrome and transitional cell carcinoma of the bladder].
Martínez-Morán
C
C
Sanz-Muñoz
C
C
Miranda-Romero
A
A
D000283:Administration, Intravesical; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001761:Bleomycin / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000150:complications* / Q000188:drug therapy; D003951:Diagnostic Errors; D006801:Humans; D017492:Keratosis, Seborrheic / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000175:diagnosis; D009378:Neoplasms, Multiple Primary / Q000150:complications* / Q000188:drug therapy; D010257:Paraneoplastic Syndromes / Q000175:diagnosis* / Q000209:etiology; D012751:Sezary Syndrome / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D001749:Urinary Bladder Neoplasms / Q000150:complications* / Q000188:drug therapy
D000970:Antineoplastic Agents; D001761:Bleomycin